| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 18, 2026 | Option exercise(M) | 5K | $17.44 | $87K | 67K |
| Aug 18, 2026 | Sell(S) | 4K | $63.27 | $259K | 62K |
| Aug 18, 2026 | Sell(S) | 900 | $63.86 | $57K | 62K |
| Aug 17, 2026 | Sell(S) | 500 | $64.16 | $32K | 62K |
| Aug 17, 2026 | Option exercise(M) | 5K | $17.44 | $87K | 67K |
| Aug 17, 2026 | Sell(S) | 2K | $62.53 | $119K | 65K |
| Aug 17, 2026 | Sell(S) | 3K | $63.50 | $165K | 62K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 18, 2026 | Option exercise(M) | 5K | — | $0 | 0 |
| Aug 17, 2026 | Option exercise(M) | 5K | — | $0 | 5K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001123343-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Travere Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.